AI
Abbington Investment Group
13F filer · CIK 0002088867Reported Jul 31, 2026
Net seller this quarter
13F portfolio value$157MU.S. long equity reported on 13F
Positions324 new · 2 closed
Net flow last quarter-$204KBuys minus sells
Top 10 positions weight29.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 31, 202632 positions | |||||
| $8.08M | 5.14% | 0.12% | 0.0% | Q3 2025 | |
| $7.6M | 4.84% | 0.01% | -12.8% | Q3 2025 | |
| $5.58M | 3.55% | 0.00% | -5.9% | Q3 2025 | |
| $4.86M | 3.09% | 0.05% | +108.5% | Q3 2025 | |
| $3.85M | 2.45% | 0.18% | +1.2% | Q3 2025 | |
| $3.37M | 2.15% | 0.19% | -0.1% | Q3 2025 | |
| $3.26M | 2.07% | 0.01% | -0.1% | Q3 2025 | |
| $3.25M | 2.07% | 0.04% | +5.8% | Q3 2025 | |
| $3.23M | 2.06% | 0.03% | -0.1% | Q3 2025 | |
| SPPROCSofgen Pharma, S.A. | $3.18M | 2.02% | 0.05% | +0.3% | Q4 2025 |
| $2.21M | 1.41% | 0.07% | +0.3% | Q4 2025 | |
| $2.19M | 1.39% | 0.00% | +1.0% | Q3 2025 | |
| $2.06M | 1.31% | 0.01% | -2.7% | Q3 2025 | |
| $1.7M | 1.08% | 0.02% | 0.0% | Q3 2025 | |
| $1.57M | 1.00% | 0.01% | Not reported | Q3 2025 | |
| $1.18M | 0.75% | 0.01% | +241.1% | Q4 2025 | |
| $1.08M | 0.69% | 0.04% | -0.2% | Q3 2025 | |
| $1M | 0.64% | 0.00% | Not reported | Q3 2025 | |
| $992K | 0.63% | 0.00% | -0.7% | Q1 2026 | |
| $965K | 0.61% | 0.38% | -2.8% | Q4 2025 | |
| $854K | 0.54% | 0.00% | +0.1% | Q1 2026 | |
| $603K | 0.38% | 0.00% | Not reported | Q3 2025 | |
| $556K | 0.35% | 0.00% | +219.4% | Q4 2025 | |
| $517K | 0.33% | 0.02% | Not reported | Q3 2025 | |
| $457K | 0.29% | 0.00% | +0.2% | Q3 2025 | |
| $257K | 0.16% | 0.00% | +0.3% | Q3 2025 | |
| $248K | 0.16% | 0.02% | Not reported | Q3 2025 | |
| $191K | 0.12% | 0.00% | +10.6% | Q3 2025 | |
| $138K | 0.09% | 0.01% | New | Q2 2026 | |
| $101K | 0.06% | 0.01% | New | Q2 2026 | |
| $84.6K | 0.05% | 0.01% | New | Q2 2026 | |
| $66.6K | 0.04% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported Apr 21, 202630 positions | |||||
| $11.2M | 6.51% | 0.01% | +74.2% | Q3 2025 | |
| $9.72M | 5.66% | 0.12% | +339.0% | Q3 2025 | |
| $5.17M | 3.01% | 0.00% | +2.6% | Q3 2025 | |
| $4.28M | 2.49% | 0.18% | +16.1% | Q3 2025 | |
| $4.25M | 2.47% | 0.17% | -0.4% | Q3 2025 | |
| SPPROCSofgen Pharma, S.A. | $4.2M | 2.44% | 0.05% | +8.9% | Q4 2025 |
| $4.18M | 2.43% | 0.03% | -37.0% | Q3 2025 | |
| $3.89M | 2.26% | 0.04% | -12.6% | Q3 2025 | |
| $3.45M | 2.01% | 0.01% | +22.5% | Q3 2025 | |
| $2.81M | 1.64% | 0.02% | +2.7% | Q3 2025 | |
| $2.55M | 1.49% | Not reported | +53.4% | Q4 2025 | |
| $2.54M | 1.48% | 0.01% | 0.0% | Q3 2025 | |
| $2.42M | 1.41% | 0.07% | +19.8% | Q4 2025 | |
| $2.13M | 1.24% | 0.00% | -2.6% | Q3 2025 | |
| $2.07M | 1.20% | 0.02% | +23.8% | Q3 2025 | |
| $2M | 1.16% | 0.01% | -67.1% | Q3 2025 | |
| $1.36M | 0.79% | 0.39% | +221.5% | Q4 2025 | |
| $1.27M | 0.74% | 0.04% | +5.8% | Q3 2025 | |
| $1.16M | 0.68% | 0.00% | -30.2% | Q3 2025 | |
| $1.1M | 0.64% | 0.00% | New | Q1 2026 | |
| $1.06M | 0.62% | 0.00% | New | Q1 2026 | |
| $659K | 0.38% | 0.00% | -15.8% | Q4 2025 | |
| $632K | 0.37% | 0.00% | -6.8% | Q3 2025 | |
| $604K | 0.35% | 0.02% | Not reported | Q3 2025 | |
| $597K | 0.35% | 0.00% | +0.2% | Q3 2025 | |
| $399K | 0.23% | 0.00% | +20.7% | Q4 2025 | |
| $251K | 0.15% | 0.00% | +0.3% | Q3 2025 | |
| $251K | 0.15% | 0.00% | -91.5% | Q3 2025 | |
| $212K | 0.12% | 0.00% | +0.2% | Q4 2025 | |
| $159K | 0.09% | 0.02% | Not reported | Q3 2025 | |
| Q4 2025Reported Jan 26, 202628 positions | |||||
| $6.43M | 4.39% | 0.04% | +2.0% | Q3 2025 | |
| $5.75M | 3.93% | 0.02% | Not reported | Q3 2025 | |
| $4.47M | 3.05% | 0.02% | +5.3% | Q3 2025 | |
| $4.18M | 2.86% | 0.00% | +45.6% | Q3 2025 | |
| $3.72M | 2.54% | 0.15% | +5.4% | Q3 2025 | |
| $3.67M | 2.51% | 0.00% | +8.1% | Q3 2025 | |
| SPPROCSofgen Pharma, S.A. | $3.51M | 2.40% | 0.05% | New | Q4 2025 |
| $3.45M | 2.36% | 0.04% | +20.7% | Q3 2025 | |
| $3.4M | 2.32% | 0.01% | +5.5% | Q3 2025 | |
| $2.82M | 1.93% | 0.02% | +6.3% | Q3 2025 | |
| $2.31M | 1.58% | 0.01% | +19.8% | Q3 2025 | |
| $2.09M | 1.43% | 0.03% | +39.0% | Q3 2025 | |
| $2.07M | 1.42% | 0.01% | +0.3% | Q3 2025 | |
| $1.94M | 1.32% | Not reported | New | Q4 2025 | |
| $1.88M | 1.28% | 0.00% | -2.8% | Q3 2025 | |
| $1.61M | 1.10% | 0.06% | New | Q4 2025 | |
| $1.54M | 1.05% | 0.00% | Not reported | Q3 2025 | |
| $1.3M | 0.89% | 0.02% | +17.2% | Q3 2025 | |
| $1.19M | 0.81% | 0.04% | +21.1% | Q3 2025 | |
| $684K | 0.47% | 0.00% | New | Q4 2025 | |
| $585K | 0.40% | 0.13% | New | Q4 2025 | |
| $556K | 0.38% | 0.02% | Not reported | Q3 2025 | |
| $556K | 0.38% | 0.00% | Not reported | Q3 2025 | |
| $498K | 0.34% | 0.00% | +0.2% | Q3 2025 | |
| $314K | 0.21% | 0.00% | New | Q4 2025 | |
| $263K | 0.18% | 0.02% | +35.7% | Q3 2025 | |
| $207K | 0.14% | 0.00% | +0.4% | Q3 2025 | |
| $201K | 0.14% | 0.00% | New | Q4 2025 | |
| Q3 2025Reported Oct 23, 202526 positions | |||||
| $6.51M | 5.57% | 0.02% | New | Q3 2025 | |
| $4.19M | 3.58% | 0.05% | New | Q3 2025 | |
| $3.78M | 3.24% | 0.02% | New | Q3 2025 | |
| $3.63M | 3.11% | 0.00% | New | Q3 2025 | |
| $3.25M | 2.78% | 0.17% | New | Q3 2025 | |
| $2.94M | 2.52% | 0.14% | New | Q3 2025 | |
| $2.65M | 2.27% | 0.00% | New | Q3 2025 | |
| $2.54M | 2.18% | 0.01% | New | Q3 2025 | |
| $2.17M | 1.85% | 0.02% | New | Q3 2025 | |
| $2.11M | 1.81% | 0.06% | New | Q3 2025 | |
| $1.97M | 1.68% | 0.01% | New | Q3 2025 | |
| $1.67M | 1.43% | 0.02% | New | Q3 2025 | |
| $1.6M | 1.37% | 0.00% | New | Q3 2025 | |
| $1.59M | 1.36% | 0.00% | New | Q3 2025 | |
| $1.3M | 1.11% | 0.00% | New | Q3 2025 | |
| $1.19M | 1.02% | 0.01% | New | Q3 2025 | |
| $895K | 0.77% | 0.03% | New | Q3 2025 | |
| $573K | 0.49% | 0.00% | New | Q3 2025 | |
| $499K | 0.43% | 0.02% | New | Q3 2025 | |
| $494K | 0.42% | 0.00% | New | Q3 2025 | |
| $333K | 0.29% | 0.00% | New | Q3 2025 | |
| $297K | 0.25% | 0.01% | New | Q3 2025 | |
| $273K | 0.23% | Not reported | New | Q3 2025 | |
| $230K | 0.20% | 0.00% | New | Q3 2025 | |
| $217K | 0.19% | 0.00% | New | Q3 2025 | |
| $66.5K | 0.06% | 0.00% | New | Q3 2025 | |
Premium opens every quarter this fund has filed